CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• A Practical Guide To Harnessing The Value Of APAC For Global Trial Success

  As Phase III costs and complexity rise, APAC offers faster enrollment, lower costs, and market access advantages, but capturing that value requires early planning and in-region expertise.

• Advancing IHC Assays From RUO To Clinical Trials And CDx

  Examine how an exploratory IHC assay evolved into a multi-indication clinical program through integrated assay development, validation, regulatory strategy, and scientific collaboration.

• Accelerate Drug Discovery With Real-Time Cell Interaction Insights

  Decoding immune cell interactions reveals critical insights for cancer therapy. Advanced imaging and spectral analysis enable precise identification of synapses, accelerating immuno-oncology research.

• AAV Capsid Analysis With Single Particle Mass Photometry

  Accurate AAV capsid ratios are critical to gene therapy efficacy. See how mass photometry delivers faster, lower-cost E/F analysis with single-particle resolution.

• Drug Development Plan Explained: DPP Templates And Examples

  Only 6.7% of Phase 1 drugs reach approval. A well-structured Drug Development Plan (DDP) can meaningfully improve your odds — learn exactly how to build one.

• How We Used Intelligent Automation to Transform Vendor Selection

  Discover how your small biotech can achieve faster timelines, improved cost control, and more strategic, transparent choices with a platform leveraging intelligent automation.

• Functional Characterization Of 3D Assembled Neurospheres

  Neural organoids and 3D spheroids offer advanced platforms for brain research and drug discovery. Discover how creating 3D neurospheres from iPSC-derived neurons and astrocytes aids in compound profiling and toxicity testing.

• Maximizing MSC Yield And Quality: A Comparative Media Study

  Maximize mesenchymal stem cell (MSC) expansion with a simplified culture process. New data demonstrates a high-performance, xeno-free media that eliminates the need for coatings or media exchanges.

• The Case For Non-Viral Circular Single-Stranded HDR Donors

  Enable efficient, low-toxicity genome editing without viral vectors. This cell-free circular ssDNA platform preserves stem cell fitness while supporting scalable manufacturing.

• Enhance Access And Improve Retention In Rare Disease Trials With HTS

  Home Trial Support (HTS) provides a solution to improving participant recruitment and retention during musculoskeletal studies.